Related Experiment Videos
Metabolic response to severe surgical illness: overview
1Department of Surgery, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA. dwilmore@partners.org
World Journal of Surgery
|April 25, 2000
Summary
Severe illness triggers a metabolic shift, redistributing body protein from muscle to vital organs. The central nervous system regulates this protein-wasting response, offering future therapeutic targets.
Area of Science:
- Metabolic responses to critical illness
- Neuroendocrinology of stress
- Skeletal muscle and visceral protein metabolism
Background:
- Severe surgical illness induces metabolic changes, mobilizing amino acids and fatty acids to support vital organs and healing.
- A key response is protein redistribution from skeletal muscle to visceral organs, potentially impairing recovery if unmanaged.
- The central nervous system (CNS) is implicated in regulating this catabolic state.
Purpose of the Study:
- To explore the role of the CNS in mediating the metabolic response to severe surgical illness.
- To investigate the potential of targeting central inflammatory pathways for therapeutic benefit.
- To examine the impact of illness on hypothalamic-pituitary function and explore hormonal replacement strategies.
Main Methods:
- Administration of proinflammatory cytokines into the brain to model injury responses.
- Central cytokine blockade as a potential therapeutic intervention.
- Assessment of hypothalamic and anterior pituitary function in late-stage illness.
Main Results:
- Infusion of low-dose proinflammatory cytokines into the brain successfully mimicked injury-induced metabolic responses.
- Central cytokine blockade demonstrated potential for safely mitigating these responses.
- Dampened hypothalamic and anterior pituitary function was observed in later stages of severe surgical illness.
Conclusions:
- The central nervous system plays a critical role in regulating the protein catabolic response to severe surgical illness.
- Central cytokine blockade represents a promising future therapeutic strategy.
- Hormonal replacement therapy warrants further investigation for managing neuroendocrine dysfunction in critical illness.